Antibodies
Cell Lines
Enzymes
Expression Vector
Luciferase Reporters
Peptides
shRNA Vector
About us
Our Mission
To provide our customers, the Basic Science Research and Clinical Laboratory communities, with world-class, high-performance products for the discovery of protein methylation pathways in cells and tissues.
To treat our customers as strategic business partners through superior research services to ensure success in the expansion of the field of protein methylation biology.
To broaden the biotechnology market through development of screening technologies to identify and commercialize drug and diagnostic candidates for the treatment of diseases such as cancer and neuro-developmental disorders.
CH3 Biosystems
Our flagship methylarginine-specific antibody, anti-mRG, is specifically designed to recognize the greatest number of methylproteins currently known. The immunizing antigen is based on a site of methylation found in a minimally required peptide sequence of consensus for arginine methylation.
This tool provides a fundamental advantage for research that is exploring the importance of protein methylation in biological systems.
Additional products now available for sale from our catalog and others in development are designed to promote simple and rapid advance in the biomedical analysis of protein methylation.
Meet the team
John M. Aletta
Director of Research
Co-Founder and the Director of Research at CH3 BioSystems. In 1997, his laboratory was the first…
Read more
Elvira Gómez Aletta, PhD
Director of Operations
CH3 BioSystems is a Woman Owned LLC based in Western New York. Dr. Elvira Gómez Aletta is a Co-Founder…
Read more
John Cong Hu
Director of Information Systems
John C. Hu is a member of the original team that organized the fundamental operating principles of CH3 BioSystems…
Read more
CH3 BioSystems Products International Distribution
For international pricing please contact any of the distributors below. Additional inquiries can be sent to customerservice@ch3biosystems.com
